From: 	Mark Jit <Mark.Jit@phe.gov.uk>
To:	"publications@lshtm.ac.uk" <publications@lshtm.ac.uk>
Date: 	22 June 2015 15:15
Subject: 	FW: Your Submission
Attachments:	Discounting.pdf

Please find an AAM and acceptance letter.

Many thanks.

Mark
________________________________________
From: ees.jvac.0.321927.edc14639@eesmail.elsevier.com [ees.jvac.0.321927.edc14639@eesmail.elsevier.com] on behalf of Vaccine [jvac@elsevier.com]
Sent: 22 June 2015 14:24
To: Mark Jit
Subject: Your Submission

Manuscript Reference No.:  JVAC‑D‑15‑00219R3
Manuscript Title: "Discounting in the evaluation of the cost‑effectiveness of a vaccination programme: a critical review"
Article Type: Review Article
Submitted to: Vaccine
Corresponding author: Dr. Mark Jit

‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑

Dear Dr. Mark  Jit,

We are pleased to inform you that your above‑referenced paper has been accepted for publication in Vaccine.  Congratulations.

Comments on the current version from its peer reviewers (and editor, if indicated) are provided below for your interest and information.

During the remaining steps of the publication process, you will be contacted separately by Elsevier's production department to execute a journal publishing agreement and, when ready, to receive page proofs of your article for error checking and correction by its authors.

When your paper is published on ScienceDirect, you want to make sure it gets the attention it deserves. To help you get your message across, Elsevier has developed a new, free service called AudioSlides: brief, webcast‑style presentations that are shown (publicly available) next to your published article. This format gives you the opportunity to explain your research in your own words and attract interest. You will receive an invitation email to create an AudioSlides presentation shortly. For more information and examples, please visit http://www.elsevier.com/audioslides.

News and embargoes

If you think your article would be interesting for a wider audience, we would be happy to hear from you. Please contact the Journal Manager, John Bailey (jd.bailey@elsevier.com), and we'll send you an information form to complete. Please inform the Journal Manager in the next three days if you are planning publicity for your article through your institution or funding body. Any publicity materials must be approved by Elsevier before release, and must not be distributed before the article has been published.

Uncorrected proofs of articles are published online on ScienceDirect as soon as they are available. As such, information about embargoes is not available. Authors can track the status of their article via the Track Your Accepted Article service.   Uncorrected articles are normally available online within two working days of you receiving the e‑mail to download the proofs.

Thank you for submitting your work to Vaccine, dedicated to improving human and animal health by disseminating the findings of immunization science.

Now that you have had your paper accepted for publication in Vaccine, the editors of the journal invite you to
make your contribution to the vital review process. If you have not yet done so, you can become a 'Reviewer' for Vaccine by contacting the support department at support@elsevier.com

With kind regards,

Bruce Y. Lee, MD, MBA
Associate Editor
Vaccine

‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑

COMMENTS OF REVIEWERS (AND EDITOR, if indicated):

Reviewers' comments:

[If any reviewers of your manuscript provided comments for the authors in a Word® .doc file or other attachment, it may be accessed and downloaded using the following instructions and URL hotlink:

If no instructions and URL hotlink appear above, then no comments were provided by attachment.]

‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑ ‑

**************************************************************************
The information contained in the EMail and any attachments is confidential and intended solely and for the attention and use of the named addressee(s). It may not be disclosed to any other person without the express authority of Public Health England, or the intended recipient, or both. If you are not the intended recipient, you must not disclose, copy, distribute or retain this message or any part of it. This footnote also confirms that this EMail has been swept for computer viruses by Symantec.Cloud, but please re‑sweep any attachments before opening or saving. http://www.gov.uk/PHE
**************************************************************************